期刊文献+

术前外周血中性粒细胞与淋巴细胞的比值和肾癌预后的关系 被引量:24

Association of neutrophil-to-lymphocyte ratio with the prognosis in patients with renal cell carcinoma
原文传递
导出
摘要 目的 探讨术前外周血中性粒细胞计数、淋巴细胞计数以及两者比值(neutrophil-to-lymphocyte ratio,NLR)与肾癌患者预后的关系.方法 回顾性分析2008年1月至2012年12月1 325例病理确诊为肾癌患者的临床病理资料及术后随访资料.采用受试者工作特征曲线法确定NLR最佳临界值,根据临界值将患者分为高NLR组和低NLR组.采用Kaplan-Meier法计算生存率,Log-rank检验比较高NLR组和低NLR组间的生存率差异.对患者年龄、症状、T分期、转移情况、病理类型及Fuhrman分级等进行单因素分析,采用Cox多因素回归分析影响肾癌患者预后的独立因素.结果 本组1 325例中1 220例获随访,随访率92.1%.随访时间2~ 87个月,中位时间40个月.1 220例的3、5年总生存率(overall survival,OS)分别为91.3%、86.9%,3、5年无复发生存率(recurrence free survival,RFS)分别为88.2%、85.8%.NLR最佳临界值为2.7,NLR≥2.7为高NLR组,NLR<2.7为低NLR组.低NLR组和高NLR组5年OS分别为91.4%、87.3%,差异有统计学意义(χ2=78.556,P <0.05);5年RFS分别为89.6%、71.9%,差异有统计学意义(χ2 =58.111,P<0.05).在153例伴有远处转移的肾癌患者中,低NLR和高NLR组患者的5年生存率分别为58.9%和22.6%,差异有统计学意义(P<0.05).单因素分析结果显示,年龄> 65岁、有临床症状、有糖尿病病史、中性粒细胞计数≥4.5、淋巴细胞计数<1.7、NLR≥2.7、伴有转移、高T分期、高Fuhrman分级是患者不良预后的影响因素(P<0.05).Cox多因素分析结果显示,年龄>65岁、NLR≥2.7、高T分期、伴有转移是肾癌患者不良预后的独立因素(P<0.05).结论 高NLR是肾癌患者不良预后的独立危险因素. Objective To explore prognostic factors of renal cell carcinoma and investigate the association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of renal cell carcinoma (RCC) in patients who received nephrectomy treatment.Methods We retrospectively reviewed the records of 1325 patients with renal cell carcinoma who underwent nephrectomy between January,2008 and December,2012.We retrospectively analyzed the clinicopathologic characteristics of patients.The optimal cutoff value for NLR was determined using receiver operating characteristic curve (ROC) analysis.We defined them as high NLR group when NLR ≥ 2.7 and low NLR group when NLR 〈 2.7.Overall survival (OS) and recurrence free survival (RFS) were estimated using the Kaplan-Meier method and compared using the logrank test.Multivariate models were used to analyze the association of NLR with clinicopathologic outcomes.Results By the end of the study, 1220 cases were followed up.The follow-up rate was 92.1%.Mean follow-up was 40 months (range 2 months to 87 months).The three-year and five-year overall survival rate were 91.3% and 86.9%, respectively.Meanwhile the three-year and five-year recurrence free survival rate were 88.2% and 85.8% ,respectively.2.7 was selected as the optimal cutoff value to differentiate between low NLR and high NLR.A NLR ≥2.7 was significantly associated with worse 5-year overall survival and worse 5-year recurrence free survival than a NLR 〈2.7,91.4% vs 87.3% ,89.6% vs 71.9% (P 〈0.05).Age 〉65, presentation mode with symptom, higher tumor stage, higher Fuhrman grade,histologic subtype,neutrophil count ≥ 4.5, lymphocyte count 〈 1.7, NLR ≥ 2.7 significantly correlated with poor OS on univariate analysis.Multivariate analysis revealed that higher tumor stage, preoperative NLR ≥ 2.7 at diagnosis were poor independent prognostic factors for OS of renal cell carcinoma.Conclusion High NLR was independent poor predictor of renal cell carcinoma.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2015年第11期812-817,共6页 Chinese Journal of Urology
关键词 肾细胞 外周血中性粒细胞与淋巴细胞比值 预后 生存率 Carcinoma,renal cell Neutrophil-to-lymphocyte ratio Prognosis Survival rate
  • 相关文献

参考文献16

  • 1Siegel RL,Miller KD,Jemal A. Cancer statistics,2015 [J]. CA Cancer J Clin,2015 ,65 :5-29.
  • 2Ohno Y, Nakashima J, Ohori M, et al. Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status [J]. Int J Clin Oncol,2014,19 : 139- 145.
  • 3张进,王共先,郭剑明,齐隽,朱冶华,陈勇辉,薛蔚,刘东明,黄翼然.肾细胞癌随访5年生存分析及预后相关因素的多中心研究[J].中华泌尿外科杂志,2015,36(2):113-117. 被引量:32
  • 4McMillan DC. The systemic inflammation-based glasgow prognostic score : A decade of experience in patients with cancer [J]. Cancer Treat Rev,2013,39:534-540.
  • 5Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis [J]. Cancer Epidemiol Biomarkers Prey,2014, 23:1204-1212.
  • 6Stotz M, Pichler M, Absenger G, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage Ill colon cancer[ J]. Br J Cancer,2014,110:435-440.
  • 7Jenne CN, Kubes P. Platelets in inflammation and infection [ J ]. Platelets, 2015,26 : 286 -292.
  • 8Viers BR, Houston Thompson R, Boorjian SA, et al. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy [ J ]. Urol Oncol,2014,32 : 1277-1284.
  • 9Ohno Y, Nakashima J, Ohori M, et al. Pretreatment neutrophil-to- lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma [ J ]. J Urol,2010, 184 : 873-878.
  • 10de Martino M,Pantuck AJ,Hofbauer S,et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma [ J]. J Urol,2013 ,190 :1999-2004.

二级参考文献37

  • 1Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow?[J].Lancet,2001,357 (9255):539-545.
  • 2Sarraf KM,Belcher E,Raevsky E,et al.Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer[J].J Thoac Cardiovas Surg,2009,137(2):425-428.
  • 3Li MX,Liu XM,Zhang XF,et al.Prognostic role of neutrophilto-lymphocyte ratio in colorectal cancer:a systematic review and meta-analysis[J].Int J Canccr,2014,134(10):2403-2413.
  • 4Mano Y,Shirabe K,Yamashita Y,et al.Preoperative neutrophilto-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma:a retrospective analysis[J].Ann Surg,2013,258(2):301-305.
  • 5Azab B,Bhatt VR,Phookan J,et al.Usefulness of the neutmphil-to lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients[J].Ann Surg Oncol,2012,19(1):217-224.
  • 6Pichler M,Hunerer GC,Stoeckigt C,et al.Validation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients[J].Br J Cancer,2013,108(4):901-907.
  • 7Shimada H,Takiguchi N,Kainuma O,et al.High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J].Gastric Cancer,2010,13(3):170-176.
  • 8Smith RA,Bosonnet L,Raraty M,et al.Preoperative plateletlymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma[J].Am Surg,2009,197(4):466-472.
  • 9Smith RA,Ghaneh P,Sutton R,et al.Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio[J].J Gastrointest Surg,2008,12(8):1422-1428.
  • 10Kwon HC,Kim SH,Oh SY,et al.Clinical significance of preoperative neutmphil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer[J].Biomarkers,2012,17 (3):216-222.

共引文献74

同被引文献132

  • 1叶海云,张小东.C反应蛋白:评价远处转移肾癌患者采用皮下注射IL-2为基础的免疫治疗后患者生存状况的生物指标[J].中华泌尿外科杂志,2005,26(5):357-357. 被引量:1
  • 2LU Y,TIANYONG F,QIANG W,et al.Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma:a prospective,randomized study[J].Can Urol Assoc J,2012,6(6);E242-248.
  • 3LI Y,GUO Z,LIU CF,et al.Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma[J].Cryobiology,2012,65(1):56-59.
  • 4WEISS JM,GREGORY ALVORD W,QUI ONES OA,et al.CD40 expression in renal cell carcinoma is associated with tumor apoptosis,CD8(+) T cellfrequency and patient survival[J].Hum Immunol,2014,75(7):614-620.
  • 5AMIN A,DUDEK AZ( LOGAN TF,et al.Survival with AGS-003,an autologous dendritic cell-based immunotherapy,in com- bination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC):Phase 2 study results[J].J Im- munotherCancer,2015,21(3):e14.
  • 6MELLA M,KAUPPILA JH,KARIHTALA P,et al.Tumor in- filtrating CD8<sup>+</sup> T lymphocyte count is indepen- dent of tumor TLR9 status in treatment na ve triple negative breast cancer and renal cell carcinoma[J],Oncoim- munology,2015,4(6):e1002726.
  • 7GONDO T,NAKASHIMA J,OHNO Y,et al.Prognostic value of neutrophil-to-lym -phocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy [J].Urology,2012,79(5):1085-1091.
  • 8Matthew J,Resnick,Jeffrey C,et al.Management of superficial and muscle-invasive urothelial cancers of the bladder [J].Curr Opin Oncol,2013,25(3):281-288.
  • 9Coussens LM,Werb Z.Inflammation and cancer [J].Nature,2002,420(6917):860-867.
  • 10Ishizuka M,Neata H,Takagi K,et al.Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer [J].Br J I tancer,2013,109(2):401-407.

引证文献24

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部